Literature DB >> 9950621

Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses.

M J Cumberbatch1, R G Hill, R J Hargreaves.   

Abstract

In vivo electrophysiological assays in anesthetized rats have been used to compare the effects of the 5HT1B/1D receptor agonist, naratriptan, on central trigeminal nociceptive processing from dural and cutaneous inputs with its effects on nociceptive processing in the spinal cord. Naratriptan inhibited responses of single trigeminal neurons, to noxious electrical and mechanical stimulation of the dura and face, dose dependently by a maximum of 67+/-3% and 70+/-18%, respectively, at 3 mg kg(-1) i.v. In contrast, naratriptan did not affect spinal dorsal horn neuronal responses to noxious mechanical stimulation of the hind-paw. These findings suggest that 5HT1B/1D receptors have differential effects on nociceptive processing in the trigeminal versus spinal dorsal horns and provide a potential explanation for the lack of general analgesic effects of brain penetrant 5HT(1B/1D) agonist antimigraine drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9950621     DOI: 10.1046/j.1468-2982.1998.1810659.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  21 in total

1.  The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.

Authors:  Valérie Kayser; Bertrand Aubel; Michel Hamon; Sylvie Bourgoin
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Inflammation induces developmentally regulated sumatriptan inhibition of spinal synaptic transmission.

Authors:  Bryony L Winters; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2020-07-08       Impact factor: 8.739

Review 3.  Where do triptans act in the treatment of migraine?

Authors:  Andrew H Ahn; Allan I Basbaum
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

4.  Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.

Authors:  Simon Akerman; Philip R Holland; Michele P Lasalandra; Peter J Goadsby
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

5.  Tissue injury regulates serotonin 1D receptor expression: implications for the control of migraine and inflammatory pain.

Authors:  Andrew H Ahn; Allan I Basbaum
Journal:  J Neurosci       Date:  2006-08-09       Impact factor: 6.167

6.  Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.

Authors:  A Laine Green; Pengfei Gu; Milena De Felice; David Dodick; Michael H Ossipov; Frank Porreca
Journal:  Cephalalgia       Date:  2013-12-11       Impact factor: 6.292

7.  Effects of a selective 5-HT(1B/1D) receptor agonist on spinal and trigeminal reflexes in the anaesthetized rabbit.

Authors:  S Jenkins; B Richardson; R W Clarke
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

8.  The complex actions of sumatriptan on rat dural afferents.

Authors:  Andrea M Harriott; Nicole N Scheff; Michael S Gold
Journal:  Cephalalgia       Date:  2012-06-18       Impact factor: 6.292

9.  5-HT(1B) but not 5-HT(6) or 5-HT(7) receptors mediate depression of spinal nociceptive reflexes in vitro.

Authors:  G Hedo; J A Lopez-Garcia
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

10.  Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat.

Authors:  L F Ferrari; J D Levine; P G Green
Journal:  Neuroscience       Date:  2016-01-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.